Kin Yip Leung

Kin Yip Leung

Director/Board Member at NOVOCURE LIMITED

Net worth: 1 M $ as of 2024-01-30

62 year
Health Technology
Commercial Services
Consumer Services

Profile

Kin Yip Leung is on the board of NovoCure Ltd.
In his past career he occupied the position of Director at Delcath Systems, Inc., Principal at Bristol Myers Squibb Co., Member of C-Change, EVP, President-Oncology & Diabetes Business at OSI Pharmaceuticals, Inc. and Group Vice President-Global Prescription Business at Pharmacia Corp.
He received an undergraduate degree from The University of Texas at Austin and a graduate degree from the University of Wisconsin.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-06-06 79,139 ( 0.07% ) 1 M $ 2024-01-30

Kin Yip Leung active positions

CompaniesPositionStart
NOVOCURE LIMITED Director/Board Member 2011-08-04
All active positions of Kin Yip Leung

Former positions of Kin Yip Leung

CompaniesPositionEnd
PERNIX THERAPEUTICS HOLDINGS INC Director/Board Member 2019-05-08
ALBANY MOLECULAR RESEARCH, INC. Director/Board Member 2016-02-03
DELCATH SYSTEMS, INC. Chairman 2014-09-14
OSI PHARMACEUTICALS, INC. Corporate Officer/Principal 2009-12-31
Corporate Officer/Principal 2003-03-31
See the detail of Kin Yip Leung's experience

Training of Kin Yip Leung

The University of Texas at Austin Undergraduate Degree
University of Wisconsin Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kin Yip Leung's experience

Connections

100 +

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

DELCATH SYSTEMS, INC.

Health Technology

NOVOCURE LIMITED

Health Technology

Private companies6

Health Technology

Commercial Services

Commercial Services

Health Technology

C-Change

Health Technology

See company connections
  1. Stock
  2. Insiders
  3. Kin Yip Leung
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW